(Q51363243)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22301406%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

title

CYP2D6*4 allele and breast cancer risk: is there any association? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22301406%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

author

Ana Fernández-Santander

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22301406%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Fernando Bandres Moya

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22301406%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

author name string

Miguel del Saz Sánchez

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22301406%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Armando Tejerina Gómez

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22301406%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

publication date

1 February 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22301406%20AND%20SRC:MED&resulttype=core&format=json

Clinical and Translational Oncology

22 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22301406%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22301406%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22301406%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

page(s)

157-159

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22301406%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s12094-012-0776-4

22 January 2020

exact match

0 references

cites work

Associations between breast cancer susceptibility gene polymorphisms and clinicopathological features

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0776-4

Role of xenobiotic metabolizing gene polymorphisms in breast cancer susceptibility and treatment outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0776-4

Pharmacogenetic variation at CYP2C9, CYP2C19, and CYP2D6 at global and microgeographic scales

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0776-4

Intronic polymorphisms of cytochromes P450.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0776-4

Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0776-4

Implication of Xenobiotic Metabolizing Enzyme gene (CYP2E1, CYP2C19, CYP2D6, mEH and NAT2) polymorphisms in breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0776-4

Genetic polymorphisms in oestrogen metabolic pathway and breast cancer: a positive association with combined CYP/GST genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0776-4

The association of CYP2D6 *10 polymorphism with breast cancer risk and clinico-pathologic characteristics in Chinese women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0776-4

Genetic polymorphisms of metabolic enzymes-CYP1A1, CYP2D6, GSTM1, and GSTT1, and gastric carcinoma susceptibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0776-4

Interaction of drug metabolizing cytochrome P450 2D6 poor metabolizers with cytochrome P450 2C9 and 2C19 genotypes modify the susceptibility to head and neck cancer and treatment response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0776-4

Polymorphism in the CYP2D6 Tamoxifen-Metabolizing Gene Influences Clinical Effect but Not Hot Flashes: Data From the Italian Tamoxifen Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0776-4

Metabolic oxidation phenotypes as markers for susceptibility to lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0776-4

Meta-analysis of studies of the CYP2D6 polymorphism in relation to lung cancer and Parkinson's disease.

21 January 2018

1 reference

12 December 2020

CYP2D6 genetic polymorphisms are associated with susceptibility to pituitary tumors

1 reference

12 December 2020

Genetic polymorphism of CYP2D6 influences susceptibility to papillary thyroid cancer

1 reference

12 December 2020

CYP2D6 worldwide genetic variation shows high frequency of altered activity variants and no continental structure

1 reference

12 December 2020

Genetic polymorphisms of drug-metabolizing enzymes CYP2D6, CYP2C9, CYP2C19 and CYP3A5 in the Greek population

1 reference

12 December 2020

Cytochrome P450 CYP2D6 genotypes: association with hair colour, Breslow thickness and melanocyte stimulating hormone receptor alleles in patients with malignant melanoma

1 reference

12 December 2020

CYP2D6 genes and risk of liver cancer

1 reference

12 December 2020

CYP2D6 genotypes in Spanish women with breast cancer

1 reference

12 December 2020

Frequency of single nucleotide polymorphisms of CYP2D6 in the Czech population

1 reference

12 December 2020

A systematic review of genetic polymorphisms and breast cancer risk.

1 reference

12 December 2020

The role of CYP2D6*4 variant in bladder cancer susceptibility in Tunisian patients

1 reference

12 December 2020